Author

Nadia Keltner

Observed name: Nadia M. Keltner

Institution: Cerus (United States)

Observed institution: Cerus (United States)

ORCID: 0009-0008-4868-5383

Observed ORCID: 0009-0008-4868-5383

OpenAlex ID: A5037248668

Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?

2024 · Nadia M. Keltner, Melissa M. Cushing, et al. · Transfusion · 12

Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trial

2024 · Melissa M. Cushing, Tobias Cohen, et al. · Trials · 7

Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex

2022 · Thea Lu, Pallavi Nahata, et al. · Pathogens · 6

Trial Of Pathogen-reduced Cryoprecipitate vs. cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): a single center, prospective, cluster randomized trial in cardiovascular surgery

2026 · Melissa M. Cushing, Tobias Cohen, et al. · Journal of Clinical Anesthesia

Works count: 4

Citation count: 25

H-index: 3

I10-index: 1